Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy

被引:20
作者
Fukui, H [1 ]
Yamamoto, M [1 ]
机构
[1] Takeda Chem Ind Ltd, Drug Safety Res Labs, Yodogawa Ku, Osaka 5328686, Japan
关键词
delayed vomiting; 5-HT3 receptor antagonist; dexamethasone; (dog);
D O I
10.1016/S0014-2999(99)00219-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the emetic effects of cisplatin and methotrexate in dogs, the effects of ondansetron on cisplatin-induced vomiting, and the effects of ondansetron, dexamethasone and a combination of the two on the vomiting induced by methotrexate. Ondansetron was administered 30 min before cisplatin administration. Ondansetron, dexamethasone or a combination of the two was administered 8, 24 and 48 h after methotrexate administration. Cisplatin (3 mg/kg, i.v.) induced acute vomiting but failed to induce delayed vomiting. The acute Vomiting was markedly inhibited by ondansetron (3 mg/kg, p.o.; 1 mg/kg, i.v.). Methotrexate (2.5 mg/kg, i.v.) caused delayed vomiting, which was partly inhibited by ondansetron (1 mg/kg, i.v.) or dexamethasone (2.5 mg/kg, i.v.). The combination of the two agents was more effective. These results suggest that methotrexate-induced emesis in dogs would be useful for studying delayed emesis. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 29 条
[1]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[2]   THE ABDOMINAL VISCERAL INNERVATION AND THE EMETIC REFLEX - PATHWAYS, PHARMACOLOGY, AND PLASTICITY [J].
ANDREWS, PLR ;
DAVIS, CJ ;
BINGHAM, S ;
DAVIDSON, HIM ;
HAWTHORN, J ;
MASKELL, L .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (02) :325-345
[3]  
BORTNOWSKI HB, 1991, AM J VET RES, V52, P1636
[4]  
CHAN H, 1997, CANC TREAT REP, V61, P797
[5]   DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].
CHANG, AE ;
SHILING, DJ ;
STILLMAN, RC ;
GOLDBERG, NH ;
SEIPP, CA ;
BAROFSKY, I ;
SIMON, RM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824
[6]   Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting - A Multicenter, Randomized, Double-Blind, Crossover Study [J].
Demulder, PHM ;
Seynaeve, C ;
Vermorken, JB ;
Vanliessum, PA ;
Molsjevdevic, S ;
Allman, EL ;
Beranek, P ;
Verweij, J .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (11) :834-840
[7]   PHARMACOLOGICAL CHARACTERIZATION OF RS-25259-197, A NOVEL AND SELECTIVE 5-HT3 RECEPTOR ANTAGONIST, IN-VIVO [J].
EGLEN, RM ;
LEE, CH ;
SMITH, WL ;
JOHNSON, LG ;
CLARK, R ;
WHITING, RL ;
HEGDE, SS .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (04) :860-866
[8]  
EGLEN RM, 1993, J PHARMACOL EXP THER, V266, P535
[9]   VAGAL AFFERENT-FIBERS AND PERIPHERAL 5-HT3 RECEPTORS MEDIATE CISPLATIN-INDUCED EMESIS IN DOGS [J].
FUKUI, H ;
YAMAMOTO, M ;
SATO, S .
JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 59 (02) :221-226
[10]   INCREASE IN SEROTONIN LEVELS IN THE DOG ILEUM AND BLOOD BY CISPLATIN AS MEASURED BY MICRODIALYSIS [J].
FUKUI, H ;
YAMAMOTO, M ;
ANDO, T ;
SASAKI, S ;
SATO, S .
NEUROPHARMACOLOGY, 1993, 32 (10) :959-968